Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans
about
Application of cross-species PET imaging to assess neurotransmitter release in brainPresentation of smoking-associated cues does not elicit dopamine release after one-hour smoking abstinence: A [11C]-(+)-PHNO PET studyIn vivo imaging of cerebral dopamine D3 receptors in alcoholism.Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNOInvesting in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewardsEx Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors.Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNOReduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humansExamining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot study.Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesiaDopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive taskAge-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study.Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism.Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.Deficits in striatal dopamine release in cannabis dependence.Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNOElevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humansOccupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in HumansImaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO.Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography.Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis useAgonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research.Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO.Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors.Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracersFenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate BrainReliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO.
P2860
Q26865012-A4E6538B-96F8-4A19-9DB9-D6795D1D3712Q28489113-F2B4C1FD-97E8-49EF-8138-6799F6EEEE7CQ33620597-9683E4DE-CAB9-4B7D-9767-8DAB2644FD8BQ33809050-694D46A0-CBB8-463D-8678-D967445E2743Q34356950-A6B4D24F-30E0-4B2C-8949-E032F2FCF486Q34906793-49A21363-B888-4E59-B34D-C2C27DE90F32Q34918396-52098404-823B-425E-BE11-717F3675E2B8Q35421107-2A048D0F-7E63-43E2-8A4F-F938D38B0D4EQ35952369-F063B1F5-65BE-4C59-A07E-341979000FC2Q35965889-0F7E0518-07B9-4230-91DF-6AD703CB2791Q36011922-BB462D8A-6775-41CE-91BB-20BA99EFB499Q36254347-00A41EC5-55B3-4603-831F-5B430ACCD9F8Q36493570-779D80C7-A5A5-4A71-B7FA-C93C4BC3012DQ36521275-A30425FA-1E4E-424F-B926-948C116B6CA1Q36610068-2B4F0896-1B1C-4C19-B70D-367B7474BB9AQ36636329-94B24576-069C-4C33-B306-8B67AE5B8B94Q36730787-8C5BD7C6-2362-4224-8F77-66868FB7A8E2Q36798993-C4FD3EDE-5885-49C7-A914-290D3CDB65B0Q37068124-E8B56904-6F02-487B-8C04-1BDAC9EF545BQ37198300-9BE773BD-74BB-4127-AE57-88739B978F6CQ37276855-A399FCC1-90EC-4BD4-A249-95A4EE1B214BQ37380723-83361A05-792E-43C2-BDA7-EFFC47590617Q37409577-3C7F422B-9813-4BA5-BD22-17FFC8B9ACCFQ37409589-DED7AED8-3530-4650-8220-30154173DAB8Q37458250-14A4BD60-0F86-4300-8D3B-4714FA5F5B8AQ37584225-4BF5AD96-7D80-473E-9383-6623823C4CBBQ37662436-32C183AD-F02E-4E63-9ED1-07016B6FBFADQ37688287-9CF0B23F-BC5B-485D-A28A-09CDC3EE6850Q37705759-BD985DE4-50B4-46D1-B2F0-420970C38813Q38065991-4CE50109-EFA4-4DF2-9D62-553D2C1DC84CQ38650497-BEDDC25A-89E3-4815-8647-EA703144EF8DQ38789021-304D923C-D5B7-48FE-90EF-38ADB1624878Q38840893-32F638A7-72B4-4984-A79F-AB6AA47A1FB4Q38848288-F85ED3A1-2CDF-496E-B572-23206E2DA526Q39635324-18B1F21C-145A-4F18-ACE3-9962DF41483CQ39656985-0EC68331-424C-4689-A5F6-AB92298D0320Q40379505-3D65001F-7C80-469A-B6B6-EF9848F5C0ADQ40702593-36970846-9A3C-4DC9-84E8-B328398C060CQ41595331-08ACB8B1-E585-415B-BB25-B9FE4AFB2022Q41840432-1C564778-8684-487F-A748-77B70104680C
P2860
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Within-subject comparison of [
@nl
Within-subject comparison of [ ...... ne challenge in healthy humans
@en
type
label
Within-subject comparison of [
@nl
Within-subject comparison of [ ...... ne challenge in healthy humans
@en
prefLabel
Within-subject comparison of [
@nl
Within-subject comparison of [ ...... ne challenge in healthy humans
@en
P2093
P2860
P356
P1476
Within-subject comparison of [ ...... ne challenge in healthy humans
@en
P2093
Alessandro Colasanti
Andri C Tziortzi
Christophe Plisson
Eugenii A Rabiner
Graham E Searle
Jasper van der Aart
John D Beaver
Marc Laruelle
Mickael Huiban
Paul Shotbolt
P2860
P304
P356
10.1038/JCBFM.2011.115
P577
2011-08-31T00:00:00Z